Nationwide Fund Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Nationwide Fund Advisors's BMY Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 1,229,700 shares — an estimated $78.4M sold.
Nationwide Fund Advisors first reported a position in BMY in Q2 2013 and held it in 18 quarters. The position peaked at $124M in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 1,229,700 Bristol-Myers Squibb shares in Q4 2017, an estimated $78.4M.
- Nationwide Fund Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's Bristol-Myers Squibb position peaked at $124M in Q2 2016.
- 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.